Pages that link to "Q47198681"
Jump to navigation
Jump to search
The following pages link to Determination of the serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in patients with either advanced small-cell lung cancer or non-small-cell lung cancer prior to treatment (Q47198681):
Displaying 24 items.
- Molecular and Cellular Effects of Hydrogen Peroxide on Human Lung Cancer Cells: Potential Therapeutic Implications (Q26744815) (← links)
- 100 years of lung cancer (Q34000402) (← links)
- Antimycobacterial drugs modulate immunopathogenic matrix metalloproteinases in a cellular model of pulmonary tuberculosis (Q34058316) (← links)
- IL-1beta induces expression of matrix metalloproteinase-9 and cell migration via a c-Src-dependent, growth factor receptor transactivation in A549 cells. (Q34116768) (← links)
- Blood-based lung cancer biomarkers identified through proteomic discovery in cancer tissues, cell lines and conditioned medium (Q35957217) (← links)
- Role of integrins in regulating proteases to mediate extracellular matrix remodeling (Q36284931) (← links)
- Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer (Q37412311) (← links)
- Highly Sensitive Marker Panel for Guidance in Lung Cancer Rapid Diagnostic Units. (Q37602084) (← links)
- The role of inflammation in lung cancer. (Q38211072) (← links)
- Targeting roles of inflammatory microenvironment in lung cancer and metastasis (Q38522515) (← links)
- Anacardic acid inhibits gelatinases through the regulation of Spry2, MMP-14, EMMPRIN and RECK. (Q38739352) (← links)
- Quantitative Secretome Analysis Reveals that COL6A1 is a Metastasis-Associated Protein Using Stacking Gel-Aided Purification Combined with iTRAQ Labeling (Q39615439) (← links)
- Detection of circulating vascular endothelial growth factor and matrix metalloproteinase-9 in non-small cell lung cancer using Luminex multiplex technology (Q41852958) (← links)
- Sequential measurements of serum matrix metalloproteinase 9 to monitor chemotherapy responses in patients with advanced non-small-cell lung cancer. (Q42737230) (← links)
- Matrix Metalloproteinase-9-Responsive Nanogels for Proximal Surface Conversion and Activated Cellular Uptake. (Q49842808) (← links)
- Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis. (Q50053859) (← links)
- Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression (Q51155840) (← links)
- Correlation between matrix metalloproteinase 9 and 18F-2-fluoro-2-deoxyglucose-positron emission tomography as diagnostic markers of lung cancer. (Q53182075) (← links)
- The matrix metalloproteinase-7 and pro-enzyme of metalloproteinase-1 as a potential marker for patients with rectal cancer without distant metastasis. (Q53655377) (← links)
- Immunohistochemical Study of Laminin-332 γ2 Chain and MMP-9 in High Risk of Malignant Transformation Oral Lesions and OSCC. (Q55167350) (← links)
- Quantum Dot Based Nano-Biosensors for Detection of Circulating Cell Free miRNAs in Lung Carcinogenesis: From Biology to Clinical Translation (Q60046068) (← links)
- Expression of Proteolytic Enzymes by Small Cell Lung Cancer Circulating Tumor Cell Lines (Q61812916) (← links)
- The effect of mesenchymal stem cells' secretome on lung cancer progression is contingent on their origin: primary or metastatic niche (Q90841086) (← links)
- MMP-2, MMP-9, TIMP-1, and TIMP-2 in the Peripheral Blood of Patients with Differentiated Thyroid Carcinoma (Q92534071) (← links)